ANTHERA PHARMACEUTICALS INC's ticker is ANTH and the CUSIP is 03674U201. A total of 86 filers reported holding ANTHERA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $43,000 | -75.8% | 13,700 | -76.3% | 0.00% | -100.0% |
| Q2 2016 | $178,000 | -57.6% | 57,767 | -50.2% | 0.00% | -66.7% |
| Q1 2016 | $420,000 | -28.3% | 115,990 | -8.1% | 0.00% | -40.0% |
| Q4 2015 | $586,000 | -20.8% | 126,190 | +3.8% | 0.01% | -16.7% |
| Q3 2015 | $740,000 | -42.8% | 121,590 | -19.0% | 0.01% | -50.0% |
| Q2 2015 | $1,294,000 | +137.4% | 150,100 | +23.1% | 0.01% | +140.0% |
| Q1 2015 | $545,000 | – | 121,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 2,535,564 | $7,835,000 | 4.00% |
| ProQuest Associates IV LLC | 1,900,000 | $5,871,000 | 2.39% |
| Abingworth LLP | 437,994 | $1,349,000 | 1.41% |
| Hilltop Park Associates LLC | 75,000 | $232,000 | 0.97% |
| Broadfin Capital, LLC | 1,154,674 | $3,568,000 | 0.35% |
| Perceptive Advisors | 1,492,156 | $4,611,000 | 0.32% |
| Rhenman & Partners Asset Management AB | 300,000 | $927,000 | 0.16% |
| Rock Springs Capital Management LP | 450,000 | $1,391,000 | 0.10% |
| WEXFORD CAPITAL LP | 145,622 | $450,000 | 0.08% |
| BOOTHBAY FUND MANAGEMENT, LLC | 15,960 | $49,000 | 0.02% |